Largest-ever Lassa fever study launches in-depth look at disease symptom
5 Mins read
Scientists in Nigeria are expanding their research into the deadly Lassa fever with the launch of a pioneering study designed to get…
Ten Years After Ebola: Learnings for Lassa Fever, “Lassa-X” and Pandemic Preparedness
5 Mins read
Oluomachukwu Omeje (Lead Writer) In global health, past epidemics are important learning experiences that shape our responses to future health emergencies. The…
Participants in Nigeria vaccinated in first-ever Phase 2 Lassa fever vaccine clinical trial, sponsored by IAVI
7 Mins read
The CEPI-funded study will evaluate the safety, tolerability, and immunogenicity of IAVI’s single dose Lassa fever vaccine candidate Key takeaways • Participants…
Are we there yet? Leveraging the Private Sector for Lassa Vaccine R&D
6 Mins read
The search for an effective vaccine against Lassa fever has gained momentum in recent years. Currently, early supportive care and the anti-viral…
CEPI: Accelerating Lassa Fever Vaccine Development in Nigeria
4 Mins read
The law of inertia, referred to as Newton’s first law of motion, states that “an object will remain at rest or in…
Institute of Lassa Fever Research and Control: Strengthening Nigeria’s Local Capacity to Lead the Lassa Fever Response
5 Mins read
By Beti Baiye and Ibukun Oguntola The driveway in the grounds of the Irrua Specialist Teaching Hospital (ISTH) is large and welcoming…
When a Virus ‘Outstays its Welcome’: Lassa Virus found in the Semen of Survivors 9 Months after Recovery – implications for public health management
5 Mins read
Editor’s Note: In this commentary Professor Sylvanus. A. Okogbenin, the Chief Medical Director of Irrua Specialist Teaching Hospital, discusses the significance of…
EDCTP and CEPI funding moves IAVI's Lassa fever vaccine candidate into advanced clinical development
4 Mins read
Global consortium of expert partners will generate proof-of-concept data to support product licensure and future access NEW YORK, THE HAGUE, AND OSLO…
Courage in the midst of fear; How Kano contained its current Lassa Fever outbreak
7 Mins read
It was the last day of 2019. Everyone, including health workers at Aminu Kano Teaching Hospital (AKTH), the largest healthcare facility in…
Themis Bioscience and CEPI Announce Initiation of Phase 1 Clinical Trial with Lassa Fever Vaccine
4 Mins read
Coalition for Epidemic Preparedness Innovations (CEPI) partnership will support Themis’ development and manufacturing of vaccine candidate — Vienna, Austria and Oslo, Norway,…
Lassa Fever: Why the Nigerian government should fund disease diagnostics for epidemic preparedness
7 Mins read
Editor’s Note: Chidindu Mmadu-Okoli is a 2019 #PreventEpidemicsNaija Fellow at Nigeria Health Watch. In this piece she writes about a doctor whose…
Decline in Lassa Fever Cases as NCDC Sustains Intensive Response
4 Mins read
Over the last five weeks, there has been a decline in the number of new cases of Lassa fever reported in Nigeria….
NCDC REVIEWS LASSA FEVER OUTBREAK RESPONSE AMIDST REDUCING NUMBER OF CASES
1 Mins read
The Nigeria Centre for Disease Control (NCDC) has reported a decrease in the number of Lassa fever cases reported weekly in the…
The fight against Lassa fever: Will it prepare Nigeria for future epidemics?
5 Mins read
It is not unusual to talk about challenges and at the same time seek out available opportunities. Speaking about opportunities presented by Lassa…